Accueil   Diary - News   All news Data Advancing the Clinical Utility of ImmunID’s ImmunTraCkeR®

Data Advancing the Clinical Utility of ImmunID’s ImmunTraCkeR®

ImmunID nouveau logo

 ImmunID today announced the publication of a short report in the Journal for ImmunoTherapy of Cancer (JITC) showing that the analysis of peripheral T cell receptor diversity using the company’s ImmunTraCkeR® assay is associated with clinical outcomes following Ipilimumab treatment in metastatic melanoma.

 

 

Read the press release